Positive fungal cultures in burn patients: A multicenter review

Journal of Burn Care and Research

Volumn 29, Issue 1, 2008, Pages 213-221

  Ballard, James ⁿ   Edelman, Linda ^l   Saffle, Jeffrey ^l   Sheridan, Robert ⁱ   Kagan, Richard ^h   Bracco, D ⁿ   Cancio, Leopoldo ^m   Cairns, Bruce ^e   Baker, Rose ^a   Fillari, Paula ^b   Wibbenmeyer, Lucy ^j   Voight, David ^f   Palmieri, Tina ⁿ   Greenhalgh, David ^g   Kemalyan, Nathan ^c   Caruso, Daniel ^d   Donison, Lorraine ^c   Richey, Karen ^d   Kessler, Mary ^e   Edwards, Paul ^f   Sanders, Johanna ^g   Lawless, Mary Beth ^g   Nelson, Judy ^h   Weber, Joan ⁱ   Newell, Ingrid ^j   Bracco, David ^k   Soueida, Rule ^k   more..

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b Saint Francis Memorial Hospital   (United States)

^c Legacy Emmanuel Hospital   (United States)

^d Maricopa County Medical Center   (United States)

^e North Carolina Jaycee Burn Center   (United States)

^f Saint Elizabeth Regional Medical Center   (United States)

^g Shriners Burn Center Northern California   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

^j UNIVERSITY OF IOWA   (United States)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

^l UNIVERSITY OF UTAH   (United States)

^m US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

ⁿ University of Utah Health Center ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; STEROID;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; BODY SURFACE; BURN; BURN PATIENT; CANDIDIASIS; CATHETER INFECTION; CHEMICAL BURN; CLINICAL DECISION MAKING; DEMOGRAPHY; DIABETES MELLITUS; ELECTRIC BURN; FEMALE; FOREIGN BODY; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; INFECTION RISK; INFECTIOUS COMPLICATION; LUNG BURN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOULD; MYCOSIS; NEUTROPENIA; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SYSTEMIC THERAPY; TOPICAL TREATMENT; TOTAL PARENTERAL NUTRITION; VENTILATOR; WOUND INFECTION;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLUS; BURNS; CANDIDA; CELLS, CULTURED; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MYCOSES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 38049048193     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31815f6ecb     Document Type: Article

References (44)

1. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998;27:781-8.
2. Swoboda SM, Merz WG, Lipsetta PA. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit. Surg Infect (Larchmt) 2003;4:345-54.
3. Cochran A, Morris SE, Edelman LS, Saffle JR. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. Surg Infect (Larchmt) 2002;3:367-74.
4. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-30.
5. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
6. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002;35:627-30.
7. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89.
8. Holzheimer R, Dralle H. Managment of mycoses in surgical patients - review of the literature. Eur J Med Res 2002;31:200-26.
9. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002;50:243-60.
10. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511.
11. Nash G, Foley F, Goodwin M, Bruck H, Greenwald K, Pruitt BA Jr. Fungal burn wound infection. JAMA 1971;215:1664-6.
12. Gelfand JA. Infections in burn patients: a paradigm for cutaneous infection in the patient at risk. Am J Med 1984;76:158-65.
13. Ekenna O, Sherertz RJ, Bingham H. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. Am J Infect Control 1993;21:189-95.
14. Esposito S. Immune system and surgical site infection. J Chemother 2001;13(Spec 1):12-6.
15. Charles PE, Doise JM, Quenot JP, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 2003;29:2162-9.
16. el-Ebiary M, Torres A, Fabregas N, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 1997;156:583-90.
17. Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000;30:14-8.
18. Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001;32:1602-7.
19. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
20. Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997;23:317-25.
21. Hodle A, Richter K, Thompson R. Infection control practices in US burn units. J Burn Care Res 2006;27:142-51.
22. Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981;75:304-11.
23. Law EJ, Kim OJ, Stieritz DD, MacMillan BG. Experience with systemic candidiasis in the burned patient. J Trauma 1972;12:543-52.
24. Mousa H, Al-Bader S, Hassan D. Correlation between fungi isolated from burn wounds and burn care units. Burns 1999;25:145-7.
25. Desai MH, Rutan RL, Heggers JP, Herndon DN. Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. Arch Surg 1992;127:159-62.
26. Dube MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994;18:77-82.
27. Becker WK, Cioffi WG Jr, McManus AT, et al. Fungal burn wound infection. A 10-year experience. Arch Surg 1991;126:44-8.
28. Bruck HM, Nash G, Stein JM, Lindberg RB. Studies on the occurrence and significance of yeasts and fungi in the burn wound. Ann Surg 1972;176:108-10.
29. Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000;15:83-90.
30. Holzheimer RG, Dralle H. Management of mycoses in surgical patients - review of the literature. Eur J Med Res 2002;7:200-26.
31. Ho KM, Rochford SA, John G. The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis. Crit Care Med 2005;33:2383-92.
32. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-4.
33. Still J, Belcher K, Law E. Management of candida septicaemia in a regional burn unit. Burns 1995;21:594-6.
34. Sheridan RL, Weber JM, Budkevich LG, Tompkins RG. Candidemia in the pediatric patient with burns. J Burn Care Rehabil 1995;16:440-3.
35. Xiao-Wu W, Herndon DN, Spies M, Sanford AP, Wolf SE. Effects of delayed wound excision and grafting in severely burned children. Arch Surg 2002;137:1049-54.
36. Spebar MJ, Lindberg RB. Fungal infection of the burn wound. Am J Surg 1979;138:879-82.
37. Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 2000;232:455-65.
38. Peck MD, Weber J, McManus A, Sheridan R, Heimbach D. Surveillance of burn wound infections: a proposal for definitions. J Burn Care Rehabil 1998;19:386-9.
39. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31:481-98.
40. Tufano R. Focus on risk factors for fungal infections in ICU patients. Minerva Anestesiol 2002;68:269-72.
41. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001;51:540-4.
42. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
43. Gastmeier P, Weigt O, Sohr D, Ruden H. Comparison of hospital-acquired infection rates in paediatric burn patients. J Hosp Infect 2002;52:161-5.
44. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis 2003;37:543-50.